Anti-Inflammatory Therapeutics Market Size and Forecast 2024-2033|Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc

Anti-inflammatory therapeutics refer to prescription medications that treat pain, lessen inflammation, and lower a high body temperature. It acts as a host response modifier and plays a crucial role in managing acute and chronic headaches, painful phases, sprains, and strain problems.

Sizing and Forecast

The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $109.88 billion in 2023 to $114.71 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives

The anti-inflammatory therapeutics market size is expected to see steady growth in the next few years. It will grow to $135.6 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Segmentation & Regional Insights

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Anti-Inflammatory Biologics

2) By Indication: Arthritis; Respiratory Diseases; Multiple Sclerosis; Psoriasis; Inflammatory Bowel Diseases; Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Distribution

North America was the largest region in the anti-inflammatory therapeutics market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Major Driver Impacting Market Growth

The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the anti-inflammatory therapeutics market going forward. Inflammatory bowel disease (IBD) is a chronic illness resulting in inflammation of the gastrointestinal tract. Anti-inflammatory therapeutics play a crucial role in treating Crohn’s disease by reducing inflammation, managing the symptoms of the disease, and reducing the risk of surgery. For instance, in July 2023, according to Oxford University Press (OUP), the university press of the University of Oxford, incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and the prevalence is 721 per 100,000 people. Therefore, the increasing prevalence of inflammatory bowel disease is driving the growth of the anti-inflammatory therapeutics market.

Key Industry Players

Major players in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

The anti-inflammatory therapeutics market report table of contents includes:

1. Executive Summary

2. Anti-Inflammatory Therapeutics Market Characteristics

3. Anti-Inflammatory Therapeutics Market Trends And Strategies

4. Anti-Inflammatory Therapeutics Market – Macro Economic Scenario

5. Global Anti-Inflammatory Therapeutics Market Size and Growth

26. South America Anti-Inflammatory Therapeutics Market

27. Brazil Anti-Inflammatory Therapeutics Market

28. Middle East Anti-Inflammatory Therapeutics Market

29. Africa Anti-Inflammatory Therapeutics Market

30. Anti-Inflammatory Therapeutics Market Competitive Landscape And Company Profiles

Top Major Players: